E-LIB Suche - Ergebnisse für: Tyulyandina, Alexandra

1

HRD Testing of Ovarian Cancer in Routine Practice: What Are..:

Kekeeva, Tatiana ; Andreeva, Yulia ; Tanas, Alexander...
International Journal of Molecular Sciences. 24 (2023) 13 - p. 10497 , 2023

Link: https://doi.org/10.3390/..

2

Detection of NTRK fusions in glioblastoma: fluorescent in s..:

Bourhis, Amélie ; Caumont, Charline ; Quintin-Roué, Isabelle...
Pathology. 54 (2022) 1 - p. 55-62 , 2022

Link: https://doi.org/10.1016/..

3

Optimizing treatment selection and sequencing decisions for..:

Goh, Jeffrey C.H. ; Gourley, Charlie ; Tan, David S P...
Gynecologic Oncology Reports. 42 (2022) - p. 101028 , 2022

Link: https://doi.org/10.1016/..

4

Phase 3, randomized, open-label study of pembrolizumab plus..:

Marth, Christian ; Tarnawski, Rafal ; Tyulyandina, Alexandra...
International Journal of Gynecologic Cancer. 32 (2021) 1 - p. 93-100 , 2021

Link: https://doi.org/10.1136/..

5

Breast cancer tumor heterogeneity has only little impact on..:

Remoué, Annabelle ; Conan-Charlet, Virginie ; Deiana, Laura...
Human Pathology. 108 (2021) - p. 51-59 , 2021

Link: https://doi.org/10.1016/..

6

Career opportunities and benefits for young oncologists in ..:

Morgan, Gilberto ; Lambertini, Matteo ; Kourie, Hampig Raphael...
ESMO Open. 1 (2016) 6 - p. e000107 , 2016

Link: https://doi.org/10.1136/..

7

Alofanib, an allosteric FGFR2 inhibitor, has potent effects..:

Tyulyandina, Alexandra ; Harrison, Daniel ; Yin, Wei...
Investigational New Drugs. 35 (2016) 2 - p. 127-133 , 2016

Link: https://doi.org/10.1007/..

8

Resolution of the advisory board on the topic: "The place o..:

Breder, Valeriy V. ; Zhukova, Liudmila G. ; Bolotina, Larisa V....
Journal of Modern Oncology. 25 (2023) 3 - p. 295-300 , 2023

Link: https://doi.org/10.26442..

9

HRD Testing of Ovarian Cancer in Routine Practice: What Are..:

Kekeeva, Tatiana ; Andreeva, Yulia ; Tanas, Alexander...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342032/. , 2023

Link: http://www.ncbi.nlm.nih...

10

Phase 3, randomized, open-label study of pembrolizumab plus..:

Marth, Christian ; Tarnawski, Rafal ; Tyulyandina, Alexandra...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762038/. , 2022

Link: http://www.ncbi.nlm.nih...

11

Breast cancer tumor heterogeneity has only little impact on..:

Remoué, Annabelle ; Conan-Charlet, Virginie ; Deiana, Laura...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.humpath.2020.11.006. , 2021

Link: https://hal.science/hal-..

12

Breast cancer tumor heterogeneity has only little impact on..:

Remoué, Annabelle ; Conan-Charlet, Virginie ; Deiana, Laura...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.humpath.2020.11.006. , 2021

Link: https://hal.science/hal-..

13

ESMO Open – Cancer Horizons / Career opportunities and bene..:

Preusser, Matthias ; Morgan, Gilberto ; Lambertini, Matteo...
vignette : https://repositorium.meduniwien.ac.at/titlepage/urn/urn:nbn:at:at-ubmuw:3-24236/128. , 2016

Link: https://resolver.obvsg.a..

14

Career opportunities and benefits for young oncologists in ..:

Morgan, Gilberto ; Lambertini, Matteo ; Kourie Hampig, Raphael...
uri/info:doi/10.1136/esmoopen-2016-000107. , 2016

Link: http://hdl.handle.net/20..

15

Career opportunities and benefits for young oncologists in ..:

Morgan, Gilberto ; Lambertini, Matteo ; Kourie, Hampig Raphael...
https://vbn.aau.dk/da/publications/3c1729bf-9964-443a-8dc5-ca794f796a5f. , 2016

Link: https://vbn.aau.dk/da/pu..